NCT02064972View on ClinicalTrials.gov

CEC Count Changes to Support GvHD Diagnosis.

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Graft vs Host DiseaseComplications of Organ Transplant Stem CellsEndothelial Dysfunction
Interventions
OTHER

Patients undergoing allo-HSCT, who manifest GvHD.

Changes in CEC counts in relation to GvHD ONSET

Trial Locations (1)

25123

A.O. Spedali Civili of Brecia, Brescia

Sponsors

Collaborators (1)

Janssen Diagnostics, LLC
All Listed Sponsors
collaborator

Janssen Diagnostics, LLC

INDUSTRY

lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER